Skip to content

13F-HR filed by EcoR1 Capital, LLC

EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2016-09-30, filed 2016-11-14, with 31 holding rows worth $325,892,000.

Accession
0001140361-16-086430
Filed
2016-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2016

A holdings report, 31 entries on the cover page, a total value of $325,892,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $325,892,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK2,810,315$44,628,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR500,576$32,367,000thousands by filing date
BRISTOL-MYERS SQUIBB CO110122908CALL500,000$26,960,000thousands by filing datecall
ASSEMBLY BIOSCIENCES INC045396108COM2,943,164$21,220,000thousands by filing date
DERMIRA INC24983L104COM522,000$17,654,000thousands by filing date
ARDELYX INC039697107COM1,310,023$16,952,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock2,611,906$16,324,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock286,612$15,044,000thousands by filing date
FIBROGEN INC31572Q808COM686,184$14,204,000thousands by filing date
GILEAD SCIENCES INC375558903COM150,000$11,868,000thousands by filing datecall
ALLERGAN PLCG0177J908COM50,000$11,516,000thousands by filing datecall
AGIOS PHARMACEUTICALS INC00847X104COM200,000$10,564,000thousands by filing date
PROTEOSTASIS THERAPEUTICS IN74373B109COM602,315$9,390,000thousands by filing date
EXACT SCIENCES CORP30063P955PUT500,000$9,285,000thousands by filing dateput
ACHAOGEN INC004449104COM1,679,707$8,046,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW846,654$7,772,000thousands by filing date
KINDRED BIOSCIENCES INC COM494577109Stock1,432,765$7,149,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM357,365$5,418,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR163,470$5,037,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X908COM CL A281,500$4,470,000thousands by filing datecall
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR219,200$4,406,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM68,600$4,120,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock946,263$3,889,000thousands by filing date
NABRIVA THERAPEUTICS AG62957M104SPONSORED ADR548,912$3,870,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM200,858$3,419,000thousands by filing date
CHIMERIX INC COM16934W106Stock598,062$3,313,000thousands by filing date
ONCOMED PHARMACEUTICALS INC COM68234X102Stock265,784$3,038,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM590,527$1,842,000thousands by filing date
CHEMOCENTRYX INC01683L106COM178,000$1,075,000thousands by filing date
SYROS PHARMACEUTICALS INC87184Q107COM63,596$882,000thousands by filing date
CASCADIAN THERAPEUTICS INC14740B901COM103,800$170,000thousands by filing datecall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-16-086430this filing2016-11-14acceptance time not in the bulk data set